Cedars-Sinai Investigator Studies Monoclonal Antibody Eculizumab in Pregnant Women With COVID-19, Preeclampsia
Even when clinical trials involving pregnant women are approved, they are often limited by funding constraints and the ethical considerations of working with this patient population.
“You have to be cautious when investigating new treatments in pregnant women,” Burwick says. “But I believe there is strong rationale to include them in clinical trials, especially when faced with a disease such as COVID-19, where there is risk of serious harm to both mother and fetus.”
Read more...